Lipe & Dalton »

Regeneron Pharmaceuticals shares owned by Lipe & Dalton

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Lipe & Dalton from 13F filings

Historical chart of Lipe & Dalton investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Lipe & Dalton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Lipe & Dalton

Quarter filed Position value Share count Share price at filing
2024-09-30 $283k 269 1052.04
2024-06-30 $283k 269 1052.04
2024-03-31 $259k 269 962.83
2023-12-31 $236k 269 877.32
2023-09-30 $221k 269 821.56
2023-06-30 $193k 269 717.47
2023-03-31 $237k 289 820.07
2022-12-31 $209k 289 723.18
2022-09-30 $213k 309 689.32
2022-06-30 $183k 309 592.23
2022-03-31 $216k 309 699.03
2021-12-31 $195k 309 631.07
2021-09-30 $126k 209 602.87
2021-06-30 $117k 209 559.81
2019-12-31 $478k 1.3k 375.20
2019-09-30 $326k 1.2k 277.68
2019-06-30 $302k 964 313.28
2019-03-31 $338k 824 410.19